HALO logo
halo search icon
Rocket Pharmaceuticals, Inc.

US$2.97

Price Change Indicator
0.05 (1.71%)
Rocket Pharmaceuticals, Inc.
RCKT · NAS

Rocket Pharmaceuticals, Inc.

Start Trading RCKT for Free

US$2.97

Price Arrow0.05 (1.71%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Earnings MomentumHALO GrowthNear Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Rocket Pharmaceuticals, Inc. Overview

RCKT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Neutral

About RCKT

icon
icon

Telephone

1.609.659.8001

icon

Address

9 Cedarbrook Drive, Cranbury, NJ 08512

Description

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.

RCKT Price Chart

Key Stats

Market Cap

US$318.85M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.19 - 6.89

Trade Value (12mth)

US$2,961,464.00

1 week

-10.15%

1 month

-20.22%

YTD

-15.61%

1 year

-55.69%

All time high

77.80

Key Fundamentals

EPS 3 yr Growth

-38.30%

EBITDA Margin

0.00%

Operating Cashflow

-$190m

Free Cash Flow Return

-48.40%

ROIC

-56.80%

Interest Coverage

-115.00

Quick Ratio

6.40

Other Data

Shares Outstanding (Fully Diluted)

112m

HALO Sector

Healthcare

Next Company Report Date

01-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

RCKT Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
08 May 26

RCKT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-2.92-2.73-2.01locklocklock
EPS (Fully Diluted)
 $locklocklocklock-2.92-2.73-2.01locklocklock
Growth
 %locklocklocklock10.26.626.4locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Rocket Pharmaceuticals, Inc. (RCKT:NAS)?
Halo FAQ
The current share price of Rocket Pharmaceuticals, Inc. (RCKT:NAS) is USD$2.97.
What is the 52-week high share price for Rocket Pharmaceuticals, Inc. (RCKT:NAS)?
Halo FAQ
The 52-week high share price for Rocket Pharmaceuticals, Inc. (RCKT:NAS) is USD$6.89.
What is the 52-week low share price for Rocket Pharmaceuticals, Inc. (RCKT:NAS)?
Halo FAQ
The 52-week low share price for Rocket Pharmaceuticals, Inc. (RCKT:NAS) is USD$2.19.
What is the dividend yield for Rocket Pharmaceuticals, Inc. (RCKT:NAS)?
Halo FAQ
Rocket Pharmaceuticals, Inc. (RCKT:NAS) does not pay a dividend.
What was Rocket Pharmaceuticals, Inc. (RCKT:NAS) last dividend payment?
Halo FAQ
Rocket Pharmaceuticals, Inc. (RCKT:NAS) does not pay a dividend.
What is the franking level for Rocket Pharmaceuticals, Inc. (RCKT:NAS)?
Halo FAQ
Rocket Pharmaceuticals, Inc. (RCKT:NAS) has a franking level of 0.00%.
In which sector is Rocket Pharmaceuticals, Inc. (RCKT:NAS) classified?
Halo FAQ
Rocket Pharmaceuticals, Inc. (RCKT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial